Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (231-240 of 333) with videos related to

Pageof 34
Sort By:
Oncology Reports|October 18, 2001
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancerM A Kuczyk, C Bokemeyer, J Hartmann, et al.
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
Oncology Reports|October 18, 2001
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphomaH Dittmann, M Sokler, C Kollmannsberger, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.
British Journal of Cancer|July 3, 2003
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trialC Bokemeyer, N Schleucher, B Metzner, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursC Bokemeyer, H J Schmoll, A Harstrick, et al.
Oncology Reports|April 16, 1999
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancerM A Kuczyk, S Machtens, C Bokemeyer, et al.
Cancer|October 1, 1993
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancerC Schöber, E Papageorgiou, A Harstrick, et al.
Pageof 34

Showing results (231-240 of 333) with videos related to

Sort By:
Pageof 34
Oncology Reports|October 18, 2001
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancerM A Kuczyk, C Bokemeyer, J Hartmann, et al.
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
Oncology Reports|October 18, 2001
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphomaH Dittmann, M Sokler, C Kollmannsberger, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.
British Journal of Cancer|July 3, 2003
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trialC Bokemeyer, N Schleucher, B Metzner, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursC Bokemeyer, H J Schmoll, A Harstrick, et al.
Oncology Reports|April 16, 1999
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancerM A Kuczyk, S Machtens, C Bokemeyer, et al.
Cancer|October 1, 1993
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancerC Schöber, E Papageorgiou, A Harstrick, et al.
Pageof 34